Quantitative Subanalysis of Optical Coherence Tomography after Treatment with Ranibizumab for Neovascular Age-Related Macular Degeneration
Open accessThe DOI matches its Crossref record; 16 of the 18 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
PURPOSE: To investigate the effects of ranibizumab on retinal morphology in patients with neovascular age-related macular degeneration (AMD) using optical coherence tomography (OCT) quantitative subanalysis. METHODS: Data from 95 patients receiving intravitreal ranibizumab for neovascular AMD were collected. StratusOCT images were analyzed using custom software that allows precise positioning of prespecified boundaries on every B-scan. Changes in thickness/volume of the retina, subretinal fluid (SRF), subretinal tissue (SRT), and pigment epithelial detachments (PEDs) at week 1 and at months 1, 3, 6, and 9 after treatment were calculated. RESULTS: Total retinal volume reached its nadir at month 1, with an average reduction of 0.43 mm(3) (P < 0.001). By month 9, this initial change had been reduced to a mean reduction of 0.32 mm(3) (P = 0.0011). Total SRF volume reached its lowest level by month 1, with an average reduction of 0.24 mm(3) (P < 0.001). This reduction lessened subsequently, to 0.18 mm(3), by month 9. There was an average 0.3-mm(3) decrease in total PED volume by month 1 (P < 0.001), and this later declined further, to 0.45 mm(3), by month 9 (P = 0.0014). Total SRT volume was reduced by an average of 0.07 mm(3) at month 1 (P = 0.0159) and subsequently remained constant. CONCLUSIONS: Although neurosensory retinal edema and SRF showed an early reduction to nadir after the initiation of ranibizumab therapy, the effect on the retina was attenuated over time, suggesting possible tachyphylaxis. PED volume showed a slower but progressive reduction. Manual quantitative OCT subanalysis may allow a more precise understanding of anatomic outcomes and their correlation with visual acuity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Keane et al 54 first suggested possible tachyphylaxis in the treatment of n-AMD after investigating retinal morphology by OCT following treatment with ranibizumab for CNV.”
From Defining response to anti-VEGF therapies in neovascular AMD (2015) · cites this paper as [54]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1×
“2 (3 [1–6]) 4.”
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Avery, R. L., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., & Giust, M. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.11.019 · Cited by 1,133
Fung, A. E., Lalwani, G. A., Rosenfeld, P. J., Dubovy, S. R., Michels, S., Feuer, W. J., Puliafito, C. A., Davis, J. L., Flynn, H. W., & Esquiabro, M. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.01.028 · Cited by 972
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
(1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080090044025 · Cited by 495
Potential Public Health Impact of Age-Related Eye Disease Study Results: AREDS Report No. 11
(2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.11.1621 · Cited by 374
Errors in Retinal Thickness Measurements Obtained by Optical Coherence Tomography
SADDA, S., WU, Z., WALSH, A., RICHINE, L., DOUGALL, J., CORTEZ, R., & LABREE, L. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.005 · Cited by 242
Self-citationKaiser, P. K., Blodi, B. A., Shapiro, H., & Acharya, N. R. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.04.030 · Cited by 217
Cited by
Schmidt-Erfurth, U., Chong, V., Loewenstein, A., Larsen, M., Souied, E., Schlingemann, R., Eldem, B., Monés, J., Richard, G., & Bandello, F. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305702 · Cited by 639
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Solomon, S. D., Lindsley, K., Vedula, S. S., Krzystolik, M. G., & Hawkins, B. S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005139.pub3 · Cited by 520
Defining response to anti-VEGF therapies in neovascular AMD
Amoaku, W. M., Chakravarthy, U., Gale, R., Gavin, M., Ghanchi, F., Gibson, J., Harding, S., Johnston, R. L., Kelly, S., Lotery, A., et al. (2015) · Eye · doi:10.1038/eye.2015.48 · Cited by 355
Sun, X., Yang, S., & Zhao, J. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s97653 · Cited by 347
Evaluation of Age-related Macular Degeneration With Optical Coherence Tomography
Keane, P. A., Patel, P. J., Liakopoulos, S., Heussen, F. M., Sadda, S. R., & Tufail, A. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.01.006 · Cited by 280
Self-citationAgrawal, R., Salman, M., Tan, K.-A., Karampelas, M., Sim, D. A., Keane, P. A., & Pavesio, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146344 · Cited by 263
Self-citationBakall, B., Folk, J. C., Boldt, H. C., Sohn, E. H., Stone, E. M., Russell, S. R., & Mahajan, V. B. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.02.017 · Cited by 229
Schmidt-Erfurth, U., Waldstein, S. M., Deak, G.-G., Kundi, M., & Simader, C. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.11.017 · Cited by 211
TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
FOROOGHIAN, F., CUKRAS, C., MEYERLE, C. B., CHEW, E. Y., & WONG, W. T. (2009) · Retina · doi:10.1097/iae.0b013e3181a2c1c3 · Cited by 179
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
Gasperini, J. L., Fawzi, A. A., Khondkaryan, A., Lam, L., Chong, L. P., Eliott, D., Walsh, A. C., Hwang, J., & Sadda, S. R. (2012) · British Journal of Ophthalmology · doi:10.1136/bjo.2011.204685 · Cited by 175
Self-citationTargeting VEGF in eye neovascularization: What's new?
Amadio, M., Govoni, S., & Pascale, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.027 · Cited by 175
Progress on retinal image analysis for age related macular degeneration
Kanagasingam, Y., Bhuiyan, A., Abràmoff, M. D., Smith, R. T., Goldschmidt, L., & Wong, T. Y. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.10.002 · Cited by 171
Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?
Binder, S. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301236 · Cited by 169
Yonekawa, Y., Andreoli, C., Miller, J. B., Loewenstein, J. I., Sobrin, L., Eliott, D., Vavvas, D. G., Miller, J. W., & Kim, I. K. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.03.030 · Cited by 166
Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
Cho, H., Shah, C. P., Weber, M., & Heier, J. S. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-303344 · Cited by 161
Alasil, T., Keane, P. A., Updike, J. F., Dustin, L., Ouyang, Y., Walsh, A. C., & Sadda, S. R. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.03.051 · Cited by 145
Self-citationCell–Matrix Interactions in the Eye: From Cornea to Choroid
Pouw, A. E., Greiner, M. A., Coussa, R. G., Jiao, C., Han, I. C., Skeie, J. M., Fingert, J. H., Mullins, R. F., & Sohn, E. H. (2021) · Cells · doi:10.3390/cells10030687 · Cited by 145
Objective Measurement of Vitreous Inflammation Using Optical Coherence Tomography
Keane, P. A., Karampelas, M. D., Sim, D. A., Sadda, S. R., Tufail, A., Sen, H. N., Nussenblatt, R. B., Dick, A. D., Lee, R., Murray, P. I., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.03.006 · Cited by 145
Self-citationTachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
Eghøj, M. S., & Sørensen, T. L. (2012) · British Journal of Ophthalmology · doi:10.1136/bjo.2011.203893 · Cited by 143
Keane, P. A., Liakopoulos, S., Chang, K. T., Wang, M., Dustin, L., Walsh, A. C., & Sadda, S. R. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.08.016 · Cited by 120
Self-citationAI-based monitoring of retinal fluid in disease activity and under therapy
Schmidt-Erfurth, U. M., Reiter, G. S., Riedl, S., Seeböck, P., Vogl, W., Blodi, B. A., Domalpally, A., Fawzi, A. A., Jia, Y., Sarraf, D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100972 · Cited by 108
Bloch, S. B., Lund‐Andersen, H., Sander, B., & Larsen, M. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.02.012 · Cited by 108
Subretinal Hyperreflective Material Imaged With Optical Coherence Tomography Angiography
Dansingani, K. K., Tan, A. C. S., Gilani, F., Phasukkijwatana, N., Novais, E. A., Querques, L., Waheed, N. K., Duker, J. S., Querques, G., Yannuzzi, L. A., et al. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.06.031 · Cited by 102
Framme, C., Wolf, S., & Wolf-Schnurrbusch, U. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5779 · Cited by 89
Keane, P. A., Grossi, C. M., Foster, P. J., Yang, Q., Reisman, C. A., Chan, K., Pető, T., Thomas, D., & Patel, P. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164095 · Cited by 92
Self-citationQuantitative Analysis of Diabetic Macular Ischemia Using Optical Coherence Tomography
Sim, D. A., Keane, P. A., Fung, S., Karampelas, M. D., Sadda, S. R., Fruttiger, M., Patel, P. J., Tufail, A., & Egan, C. A. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12677 · Cited by 92
Self-citationResistance to antivascular endothelial growth factor treatment in age-related macular degeneration
Georgalas, I., Perganta, Vakalis, Vachtsevanos, Tranos, Asteriades, S., & Koukoula (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s43470 · Cited by 86
Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept
Hara, C., Wakabayashi, T., Fukushima, Y., Sayanagi, K., Kawasaki, R., Sato, S., Sakaguchi, H., & Nishida, K. (2019) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-019-04456-2 · Cited by 70
Sim, D. A., Keane, P. A., Mehta, H., Fung, S., Zarranz‐Ventura, J., Fruttiger, M., Patel, P. J., Egan, C. A., & Tufail, A. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11085 · Cited by 68
Self-citationRush, R. B. (2023) · Clinical ophthalmology · doi:10.2147/opth.s424315 · Cited by 67
Kashani, A. H., Keane, P. A., Dustin, L., Walsh, A. C., & Sadda, S. R. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2691 · Cited by 63
Self-citationKeane, P. A., Patel, P. J., Ouyang, Y., Chen, F. K., Ikeji, F., Walsh, A. C., Tufail, A., & Sadda, S. R. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4846 · Cited by 63
Self-citationSwitch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice
Pinheiro-Costa, J., Costa, J. M. M., Beato, J. N., Freitas‐da‐Costa, P., Brandão, E., Falcão, M. S., Falcão‐Reis, F., & Carneiro, Â. M. (2015) · Ophthalmologica · doi:10.1159/000381221 · Cited by 60
Erratum: Defining response to anti-VEGF therapies in neovascular AMD
Amoaku, W. M. K., Chakravarthy, U., Gale, R. P., Gavin, M., Ghanchi, F. D., Gibson, J., Harding, S. P., Johnston, R. L., Kelly, S. P., Lotery, A. J., et al. (2015) · Eye · doi:10.1038/eye.2015.159 · Cited by 59
Ristau, T., Keane, P. A., Walsh, A. C., Engin, A., Mokwa, N., Kirchhof, B., Sadda, S. R., & Liakopoulos, S. (2013) · Ophthalmologica · doi:10.1159/000354551 · Cited by 57
Self-citationHemeida, T. S., Keane, P. A., Dustin, L., Sadda, S. R., & Fawzi, A. A. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.167627 · Cited by 56
Self-citationNg, B., Kolli, H., Ajith-Kumar, N., Azzopardi, M., Logeswaran, A., Buensalido, J., Mushtaq, B., Chavan, R., & Chong, Y. J. (2024) · Life · doi:10.3390/life14020193 · Cited by 55
Forooghian, F., Chew, E. Y., Meyerle, C. B., Cukras, C., & Wong, W. T. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2009.01773.x · Cited by 54
Drusen with Accompanying Fluid underneath the Sensory Retina
Sikorski, B. L., Sampson, D. M., Kałuzny, J. J., Szkulmowski, M., Kowalczyk, A. A., & Wojtkowski, M. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.04.017 · Cited by 55
Charafeddin, W., Nittala, M. G., Oregón-Miranda, A. A., & Sadda, S. R. (2015) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20150521-03 · Cited by 54
Self-citationHeussen, F. M., Shao, Q., Ouyang, Y., Joussen, A. M., & Müller, B. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2553-7 · Cited by 53
Self-citationFramme, C., Panagakis, G., & Birngruber, R. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4496 · Cited by 52
Mantel, I., Gillies, M. C., & Souied, E. H. (2018) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2018.02.004 · Cited by 52
Intravitreal Injection Therapy: Current Techniques and Supplemental Services
Lam, L. A., Mehta, S., Lad, E. M., Emerson, G. G., Jumper, J. M., Awh, C. C., & for the Task Force on Intravitreal Injection Supplemental Services (2021) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264211028441 · Cited by 50
Keane, P. A., Liakopoulos, S., Chang, K. T., Heussen, F. M., Ongchin, S. C., Walsh, A. C., & Sadda, S. R. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.138891 · Cited by 50
Self-citationRestoration of Outer Retinal Layers After Aflibercept Therapy in Exudative AMD: Prognostic Value
Coscas, F., COSCAS, G. J., Lupidi, M., Dirani, A., Srour, M., Semoun, O., Français, C., & Souied, E. H. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16735 · Cited by 50
Gray Hyper-Reflective Subretinal Exudative Lesions in Exudative Age-Related Macular Degeneration
Orès, R., Puche, N., Querques, G., Blanco-Garavito, R., Merle, B. M. J., COSCAS, G. J., Oubraham, H., Semoun, O., & Souied, E. H. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.04.025 · Cited by 47
Barthelmes, D., Campain, A. E., Nguyen, P. V., Arnold, J., McAllister, I. L., Simpson, J. M., Hunyor, A. P., Guymer, R. H., Essex, R. W., Morlet, N., et al. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-308090 · Cited by 45
Antimycotic Activity of Ozonized Oil in Liposome Eye Drops against Candida spp.
Celenza, G., Iorio, R., Cracchiolo, S., Petricca, S., Costagliola, C., Cinque, B., Segatore, B., Amicosante, G., & Bellio, P. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.8.4 · Cited by 46
Cheong, K. X., Teo, K. Y. C., & Cheung, C. M. G. (2020) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2020.05.003 · Cited by 43
Predicting visual outcomes for macular disease using optical coherence tomography
Keane, P. A., & Sadda, S. R. (2011) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2011.01.003 · Cited by 41
Self-citationBontzos, G., Bagheri, S., Ioannidi, L. D., Kim, I. K., Datseris, I., Gragoudas, E. S., Kabanarou, S. A., Miller, J. W., Tsilimbaris, M. K., & Vavvas, D. G. (2019) · Ophthalmology Retina · doi:10.1016/j.oret.2019.11.004 · Cited by 39
Imai, A., Toriyama, Y., Iesato, Y., Hirabayashi, K., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., Tanaka, M., Liu, T., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.01.014 · Cited by 36
Souied, E. H., Addou-Regnard, M., Ohayon, A., Semoun, O., Querques, G., Blanco-Garavito, R., Bunod, R., Jung, C., Sikorav, A., & Mière, A. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2020.02.016 · Cited by 35
Automated phone and mail population outreach to promote colorectal cancer screening.
Kempe, K. L., Shetterly, S. M., France, E. K., & Levin, T. R. (2012) · PubMed · Cited by 35
Choroidal assessment in idiopathic panuveitis using optical coherence tomography
Karampelas, M. D., Sim, D. A., Keane, P. A., Zarranz‐Ventura, J., Patel, P. J., Tufail, A., Westcott, M. C., Lee, R., & Pavesio, C. E. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2330-7 · Cited by 32
Self-citationSadda, S. R., Liakopoulos, S., Keane, P. A., Ongchin, S. C., Msutta, S., Chang, K. T., & Walsh, A. C. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1193-4 · Cited by 31
Self-citationFixation stability as a goal in the treatment of macular disease
Mandelcorn, M. S., Podbielski, D. W., & Mandelcorn, E. D. (2013) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2013.05.006 · Cited by 31
Emerging therapeutic approaches in the management of retinal angiogenesis and edema
Truong, A., Wong, T. Y., & Khachigian, L. M. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0709-z · Cited by 30
Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration
Patel, P. N., Patel, P. A., Land, M. R., Bakerkhatib-Taha, I., Ahmed, H., & Sheth, V. S. (2022) · Biomedicines · doi:10.3390/biomedicines10081884 · Cited by 29
Bevacizumab and Neovascular Age Related Macular Degeneration: Pathogenesis and Treatment
El-Mollayess, G. M., Noureddine, B. N., & Bashshur, Z. F. (2011) · Seminars in Ophthalmology · doi:10.3109/08820538.2010.545100 · Cited by 29
Massougnes, S. D., Dirani, A., Ambresin, A., Decugis, D., Marchionno, L., & Mantel, I. (2015) · Retina · doi:10.1097/iae.0000000000000813 · Cited by 29
Barañano, A. E., Keane, P. A., Ruiz‐Garcia, H., Walsh, A. C., & Sadda, S. R. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02398.x · Cited by 28
Self-citationPiotrowska, M., Spodzieja, M., Kuncewicz, K., Rodziewicz‐Motowidło, S., & Orlikowska, M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113694 · Cited by 27
Balaskas, K., Karampelas, M. D., Horani, M., Hotu, O., Keane, P. A., & Aslam, T. M. (2016) · Retina · doi:10.1097/iae.0000000000001342 · Cited by 27
Self-citationAdrenomedullin-RAMP2 System Is Crucially Involved in Retinal Angiogenesis
Iesato, Y., Toriyama, Y., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., Yoshizawa, T., Koyama, T., Uetake, R., Yang, L., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.015 · Cited by 25
Keane, P. A., Heussen, F. M., Ouyang, Y., Mokwa, N., Walsh, A. C., Tufail, A., Sadda, S. R., & Patel, P. J. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8130 · Cited by 25
Self-citationCheng, Y., Li, Y., Huang, X. Y., & Qu, Y. (2017) · Retina · doi:10.1097/iae.0000000000002005 · Cited by 25
Subjective perception versus objective outcome after intravitreal ranibizumab for exudative AMD
Koch, K. R., Muether, P. S., Hermann, M. M., Hoerster, R., Kirchhof, B., & Fauser, S. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1792-8 · Cited by 24
Current and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis
Todorich, B., Yiu, G. C., & Hahn, P. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.890047 · Cited by 24
Hirabayashi, K., Tanaka, M., Imai, A., Toriyama, Y., Iesato, Y., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., Tanaka, M., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.10.021 · Cited by 24
Kong, X., Ho, A., Muñoz, B. E., West, S. K., Strauss, R. W., Jha, A., Ervin, A., Buzas, J. S., Singh, M. S., Hu, Z. J., et al. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.3.46 · Cited by 23
Bashshur, Z. F., Schakal, A. R., El-Mollayess, G. M., Arafat, S. N., Jaafar, D., & Salti, H. I. (2010) · Retina · doi:10.1097/iae.0b013e3181fe54ab · Cited by 23
Ranjbar, M., Kurz, M., Holzhey, A., Melchert, C., Rades, D., & Grisanti, S. (2016) · Medicine · doi:10.1097/md.0000000000005729 · Cited by 20
Reiter, G. S., & Schmidt-Erfurth, U. M. (2022) · Therapeutic Advances in Ophthalmology · doi:10.1177/25158414221083363 · Cited by 20
You, J. Y., Chung, H., & Kim, H. C. (2012) · Current Eye Research · doi:10.3109/02713683.2011.647227 · Cited by 19
Hyperreflective material as a biomarker in neovascular age-related macular degeneration
Casalino, G., Scialdone, A., Bandello, F. M., & Chakravarthy, U. (2020) · Expert Review of Ophthalmology · doi:10.1080/17469899.2020.1745062 · Cited by 19
Querques, G., Tran, T. H. C., Forte, R., Querques, L., Bandello, F. M., & Souied, E. H. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1831-5 · Cited by 19
Hussein, Z. R., Omar, S. K., Alkazraji, R. A. M., Alsamarrai, A. N., Alrubaye, H. S., & Al-Hussaniy, H. A. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2022-0356 · Cited by 18
Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration
Gamulescu, M., Radeck, V. M. M., Lustinger, B., Fink, B., & Helbig, H. (2009) · International Ophthalmology · doi:10.1007/s10792-009-9318-7 · Cited by 18
Ersoy, L., Ristau, T., Kirchhof, B., & Liakopoulos, S. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2519-9 · Cited by 18
Self-citationCoscas, F., Querques, G., Forte, R., Terrada, C., COSCAS, G. J., & Souied, E. H. (2012) · Retina · doi:10.1097/iae.0b013e318240a529 · Cited by 18
Mataix, J., Palacios, E., Desco, C., García-Pous, M., & Návea, A. (2010) · Retina · doi:10.1097/iae.0b013e3181d2f172 · Cited by 17
Liu, T., Hui, L., Wang, Y., Guo, J., Li, R., Su, J., Chen, J., Xin, X.-M., & Li, W.-H. (2012) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-012-2185-3 · Cited by 17
Gene Expression Within a Human Choroidal Neovascular Membrane Using Spatial Transcriptomics
Voigt, A. P., Mullin, N. K., Navratil, E., Flamme‐Wiese, M. J., Lin, L., Scheetz, T. E., Han, I. C., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.13.40 · Cited by 16
Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results
Cardoso, P., Pinheiro, A. F., Meira, J., Pedrosa, A. C., Falcão, M. S., Pinheiro-Costa, J., Falcão‐Reis, F., & Carneiro, Â. M. (2017) · Journal of Ophthalmology · doi:10.1155/2017/6835782 · Cited by 16
Hsia, N., Lin, C., Chen, H., Chang, C.-H., Bair, H., Lai, C., Lin, J., Chen, W., Tien, P., Wu, W., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.649979 · Cited by 15
Wolf, A., Rüping, J., Neubauer, A. S., Mayer, W. J., ULBIG, M. W., Haritoglou, C., Holz, F. G., Eter, N., & Kampik, A. (2013) · Retina · doi:10.1097/iae.0b013e318287d9be · Cited by 14
Barış, M. E., Menteş, J., Afrashı, F., Nalçacı, S., & Akkın, C. (2020) · Turkish Journal of Ophthalmology · doi:10.4274/tjo.galenos.2020.38488 · Cited by 14
Yufeng, X., Hong, N., Mingzhi, S., Weixin, Z., & Ye, P. (2025) · BMC Ophthalmology · doi:10.1186/s12886-025-04212-7 · Cited by 13
Implementation studies of ranibizumab for neovascular age‐related macular degeneration
Bloch, S. B. (2013) · Acta Ophthalmologica · doi:10.1111/aos.12272 · Cited by 13
Serrano-Aguilar, P. G., González, R. A., Antón-Canalís, L., Guerra-Artal, C., Ramallo‐Fariña, Y., Gómez-Ulla, F., & Nadal, J. (2011) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300660 · Cited by 13
EFFECT OF RANIBIZUMAB RETREATMENT FREQUENCY ON NEUROSENSORY RETINAL VOLUME IN NEOVASCULAR AMD
Keane, P. A., Chang, K. T., Liakopoulos, S., Jivrajka, R. V., Walsh, A. C., & Sadda, S. R. (2009) · Retina · doi:10.1097/iae.0b013e31819b17a5 · Cited by 13
Self-citationMoraes, G., Struyven, R., Wagner, S. K., Liu, T., Chong, D., Abbas, A., Chopra, R., Patel, P. J., Balaskas, K., Keenan, T. D. L., et al. (2024) · Ophthalmology Science · doi:10.1016/j.xops.2024.100570 · Cited by 12
Self-citationTachyphylaxis during ranibizumab treatment of exudative age-related macular degeneration.
Doğuizi, S., Özdek, Ş., & Yüksel, S. (2015) · International Journal of Ophthalmology · doi:10.3980/j.issn.2222-3959.2015.04.37 · Cited by 12
Shiragami, C., Ono, A., Kobayashi, M., Manabe, S., Yamashita, A., & Shiraga, F. (2014) · Medicine · doi:10.1097/md.0000000000000116 · Cited by 12
Framme, C., Panagakis, G., Walter, A., Gamulescu, M., Herrmann, W. A., & Helbig, H. (2010) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2010.01940.x · Cited by 11
Dirani, A., & Mantel, I. (2018) · Clinical ophthalmology · doi:10.2147/opth.s160367 · Cited by 11
Kim, K. Y., Kwak, H. W., Kim, M., Kim, Y. G., & Yu, S. (2013) · Retina · doi:10.1097/iae.0b013e318289930e · Cited by 10
Switching Intravitreal anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration
Küçükerdönmez, C., Gelişken, F., Yoeruek, E., Bartz‐Schmidt, K. U., & Leitritz, M. A. (2014) · European Journal of Ophthalmology · doi:10.5301/ejo.5000480 · Cited by 10
Metadata
- Authors
- Keane, P. A., Liakopoulos, S., Ongchin, S. C., Heussen, F. M., Msutta, S., Chang, K. T., Walsh, A. C., & Sadda, S. R.
- Affiliations
- University of Southern California (US)
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2008-07-01
- Volume
- 49
- Issue
- 7
- Pages
- 3115
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- PMC
- PMC2673192
- OpenAlex
- W2051103210
- Cited by
- 145
- References
- 16
- Citations by year
- 2025: 5 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 4 · 2019: 8 · 2018: 7 · 2017: 8 · 2016: 8 · 2015: 12 · 2014: 9 · 2013: 23 · 2012: 13
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Eye Institute (P30EY003040, R21EY015914, #EY03040, R01EY014375)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- ranibizumab, neovascular age-related macular degeneration, retinal volume, subretinal fluid, pigment epithelial detachment, tachyphylaxis, intravitreal anti-VEGF therapy, retinal thickness
- MeSH terms
- Ranibizumab, Aged, Aged, 80 and over, Antibodies, Monoclonal, Body Fluids, Diagnosis, Computer-Assisted, Female, Follow-Up Studies, Humans, Macular Degeneration, Male, Middle Aged, Papilledema, Pigment Epithelium of Eye, Retina, Retinal Detachment, Retrospective Studies, Time Factors, Choroidal Neovascularization, Tomography, Optical Coherence, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.